cell-derived CD39-CD73 exosomes (Arthrogen)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecell-derived CD39-CD73 exosomes (Arthrogen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapyBiologics > Exosomes
Mechanisms of Action5'-nucleotidase stimulantsEctonucleoside triphosphate diphosphohydrolase 1 agonists
Targets5'-nucleotidaseEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArthrogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArthrogen
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A